The estimated Net Worth of Stephen Furlong is at least $3.58 Milión dollars as of 27 February 2024. Mr. Furlong owns over 25,257 units of Neuronetics Inc stock worth over $357,994 and over the last 5 years he sold STIM stock worth over $1,462,838. In addition, he makes $1,758,090 as Vice President, Chief Financial Officer a Office of the President at Neuronetics Inc.
Stephen has made over 20 trades of the Neuronetics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 25,257 units of STIM stock worth $83,348 on 27 February 2024.
The largest trade he's ever made was selling 30,486 units of Neuronetics Inc stock on 20 May 2021 worth over $458,509. On average, Stephen trades about 9,104 units every 56 days since 2019. As of 27 February 2024 he still owns at least 483,776 units of Neuronetics Inc stock.
You can see the complete history of Mr. Furlong stock trades at the bottom of the page.
Stephen Furlong serves as Vice President, Chief Financial Officer, Office of the President of the Company. He has served as our Vice President and Chief Financial Officer since July 2019 and as a member of the Office of the President of the Company since March 5, 2020 following Mr. Thatcher’s resignation as our Chief Executive Officer and President. Prior to joining the company, Mr. Furlong worked at Metabolon, a private life science company in metabolomics, a phenotyping technology for advancing biomarker discovery, diagnostic testing and precision medicine, from November 2017 to July 2019, where he most recently served as Senior Vice President of Finance and Corporate Secretary. Prior to joining Metabolon, Mr. Furlong was Vice President Finance at Verscend Technologies from February 2017 to June 2017. From April 2015 to September 2016, he served as Chief Financial Officer of Rapid Micro Biosystems, which manufactures and distributes products for detection of microbial contamination. Before joining Rapid Micro Biosystems, Mr. Furlong spent 14 years at Hologic, a publicly-traded medical technology company, where he held a number of roles of increasing responsibilities, most recently Senior Vice President, Finance and Sales Administration. Prior to his experience at Hologic, Mr. Furlong held positions at Safety 1st, Stratus Computer Inc., and Raytheon Company. Mr. Furlong received his B.A. in Political Science from The Pennsylvania State University and his Master of Finance degree from Bentley University.
As the Vice President, Chief Financial Officer a Office of the President of Neuronetics Inc, the total compensation of Stephen Furlong at Neuronetics Inc is $1,758,090. There are 1 executives at Neuronetics Inc getting paid more, with Daniel Guthrie having the highest compensation of $1,937,180.
Stephen Furlong is 56, he's been the Vice President, Chief Financial Officer a Office of the President of Neuronetics Inc since 2020. There are 8 older and 3 younger executives at Neuronetics Inc. The oldest executive at Neuronetics Inc is Wilfred Jaeger, 64, who is the Independent Director.
Stephen's mailing address filed with the SEC is C/O NEURONETICS, INC., 3222 PHOENIXVILLE PIKE, MALVERN, PA, 19355.
Over the last 6 years, insiders at Neuronetics Inc have traded over $9,582,393 worth of Neuronetics Inc stock and bought 1,499,267 units worth $4,708,316 . The most active insiders traders include Capital Llc Cannell, Ronald Hunt a Glenn P Muir. On average, Neuronetics Inc executives and independent directors trade stock every 20 days with the average trade being worth of $21,199. The most recent stock trade was executed by Glenn P Muir on 5 September 2024, trading 25,000 units of STIM stock currently worth $20,000.
with neurostar advanced therapy, neuronetics, inc., is the market leader in transcranial magnetic stimulation technology for the treatment of major depressive disorder. based in malvern, pa, we are a privately held medical device company focused on developing non-invasive therapies for psychiatric and neurological disorders using mri-strength magnetic field pulses. we are the first company to have a non-systemic and non-invasive depression treatment cleared by the fda for patients who have not benefited from prior antidepressant medication. neuronetics markets neurostar advanced therapy throughout the united states and select markets around the world. if you have questions or comments about neurostar, please e-mail us at customersupport@neuronetics.com. for u.s. phone support, please call us at (877) 600-7555, for international customers, our number is +1 (610) 640-4207.
Neuronetics Inc executives and other stock owners filed with the SEC include: